Myokarditis nach mRNA-Impfung

This article presents the case of a 15-year-old adolescent presenting with myocarditis 4 days after receiving the 2nd dose of BNT162b2 mRNA vaccine (Comirnaty®) with no other identifiable cause. The main clinical symptom at presentation was chest pain. We found an elevated level of Troponin‑I with p...

Descripción completa

Detalles Bibliográficos
Autores principales: Formanek, Anna, Wagner, Thomas, Newrkla, Stephan, Kurz, Herbert
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Vienna 2022
Materias:
Fallbericht
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9425779/
https://www.ncbi.nlm.nih.gov/pubmed/36040634
http://dx.doi.org/10.1007/s10354-022-00959-6
_version_ 1784778529504755712
author Formanek, Anna
Wagner, Thomas
Newrkla, Stephan
Kurz, Herbert
author_facet Formanek, Anna
Wagner, Thomas
Newrkla, Stephan
Kurz, Herbert
author_sort Formanek, Anna
collection PubMed
description This article presents the case of a 15-year-old adolescent presenting with myocarditis 4 days after receiving the 2nd dose of BNT162b2 mRNA vaccine (Comirnaty®) with no other identifiable cause. The main clinical symptom at presentation was chest pain. We found an elevated level of Troponin‑I with preserved left ventricular systolic function. The cardiac MRI showed a clear pathologic result. With symptomatic therapy and strict bed rest, the symptoms resolved quickly and revealed a mild course.
format Online
Article
Text
id pubmed-9425779
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Springer Vienna
record_format MEDLINE/PubMed
spelling pubmed-94257792022-08-30 Myokarditis nach mRNA-Impfung Formanek, Anna Wagner, Thomas Newrkla, Stephan Kurz, Herbert Wien Med Wochenschr Fallbericht This article presents the case of a 15-year-old adolescent presenting with myocarditis 4 days after receiving the 2nd dose of BNT162b2 mRNA vaccine (Comirnaty®) with no other identifiable cause. The main clinical symptom at presentation was chest pain. We found an elevated level of Troponin‑I with preserved left ventricular systolic function. The cardiac MRI showed a clear pathologic result. With symptomatic therapy and strict bed rest, the symptoms resolved quickly and revealed a mild course. Springer Vienna 2022-08-30 2023 /pmc/articles/PMC9425779/ /pubmed/36040634 http://dx.doi.org/10.1007/s10354-022-00959-6 Text en © The Author(s), under exclusive licence to Springer-Verlag GmbH Austria, ein Teil von Springer Nature 2022 This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic.
spellingShingle Fallbericht
Formanek, Anna
Wagner, Thomas
Newrkla, Stephan
Kurz, Herbert
Myokarditis nach mRNA-Impfung
title Myokarditis nach mRNA-Impfung
title_full Myokarditis nach mRNA-Impfung
title_fullStr Myokarditis nach mRNA-Impfung
title_full_unstemmed Myokarditis nach mRNA-Impfung
title_short Myokarditis nach mRNA-Impfung
title_sort myokarditis nach mrna-impfung
topic Fallbericht
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9425779/
https://www.ncbi.nlm.nih.gov/pubmed/36040634
http://dx.doi.org/10.1007/s10354-022-00959-6
work_keys_str_mv AT formanekanna myokarditisnachmrnaimpfung
AT wagnerthomas myokarditisnachmrnaimpfung
AT newrklastephan myokarditisnachmrnaimpfung
AT kurzherbert myokarditisnachmrnaimpfung

Ejemplares similares